Maslinic Acid Suppresses Osteoclastogenesis And Prevents Ovariectomy-Induced Bone Loss By Regulating Rankl-Mediated Nf-Kappa B And Mapk Signaling Pathways
Chenghai Li,Zhengfeng Yang,Zhenxi Li,Yu Ma,Lipeng Zhang,Chunbing Zheng,Wenwei Qiu,Xian Wu,Xiu Wang,Hui Li,Jie Tang,Min Qian,Dali Li,Ping Wang,Jian Luo,Mingyao Liu
DOI: https://doi.org/10.1002/jbmr.242
IF: 6.39
2011-01-01
Journal of Bone and Mineral Research
Abstract:Activation of NF-kappa B and MAPK/activator protein 1 (AP-1) signaling pathways by receptor activator NF-kappa B ligand (RANKL) is essential for osteoclast activity. Targeting NF-kappa B and MAPK/AP-1 signaling to modulate osteoclast activity has been a promising strategy for osteoclast-related diseases. In this study we examined the effects of maslinic acid (MA), a pentacyclic triterpene acid that is widely present in dietary plants, on RANKL-induced osteoclastogenesis, osteoclast function, and signaling pathways by in vitro and in vivo assay systems. In mouse bone marrow monocytes (BMMs) and RAW264.7 cells, MA inhibited RANKL-induced osteoclastogenesis in a dose-dependent manner within nongrowth inhibitory concentration, and MA decreased osteoclastogenesis-related marker gene expression, including TRACP, MMP9, c-Src, CTR, and cathepsin K. Specifically, MA suppressed osteoclastogenesis and actin ring formation at early stage. In ovariectomized mice, administration of MA prevented ovariectomy-induced bone loss by inhibiting osteoclast activity. At molecular levels, MA abrogated the phosphorylation of MAPKs and AP-1 activity, inhibited the I kappa B alpha phosphorylation and degradation, blocked NF-kappa B/p65 phosphorylation, nuclear translocation, and DNA-binding activity by downregulating RANK expression and blocking RANK interaction with TRAF6. Together our data demonstrate that MA suppresses RANKL-induced osteoclastogenesis through NF-kappa B and MAPK/AP-1 signaling pathways and that MA is a promising agent in the treatment of osteoclast-related diseases such as osteoporosis. (c) 2011 American Society for Bone and Mineral Research.